These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34683850)

  • 1. Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.
    Cooper I; Ravid O; Rand D; Atrakchi D; Shemesh C; Bresler Y; Ben-Nissan G; Sharon M; Fridkin M; Shechter Y
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells.
    Cooper I; Schnaider-Beeri M; Fridkin M; Shechter Y
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the transport of vanadium in blood serum.
    Sanna D; Micera G; Garribba E
    Inorg Chem; 2009 Jul; 48(13):5747-57. PubMed ID: 19514735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanadium(V) tris-3,5-di-tert-butylcatecholato complex: Links between speciation and anti-proliferative activity in human pancreatic cancer cells.
    Griffin E; Levina A; Lay PA
    J Inorg Biochem; 2019 Dec; 201():110815. PubMed ID: 31520878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
    Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
    Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
    Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
    J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.
    Kim I; Kim TH; Ma K; Lee ES; Kim D; Oh KT; Lee DH; Lee KC; Youn YS
    Bioconjug Chem; 2010 Aug; 21(8):1513-9. PubMed ID: 20715855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speciation of potential anti-diabetic vanadium complexes in real serum samples.
    Sanna D; Ugone V; Serra M; Garribba E
    J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells.
    Merlot AM; Sahni S; Lane DJ; Fordham AM; Pantarat N; Hibbs DE; Richardson V; Doddareddy MR; Ong JA; Huang ML; Richardson DR; Kalinowski DS
    Oncotarget; 2015 Apr; 6(12):10374-98. PubMed ID: 25848850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution.
    Nechay BR; Nanninga LB; Nechay PS
    Arch Biochem Biophys; 1986 Nov; 251(1):128-38. PubMed ID: 3789729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
    Kamps JA; Swart PJ; Morselt HW; Pauwels R; De Béthune MP; De Clercq E; Meijer DK; Scherphof GL
    Biochim Biophys Acta; 1996 Jan; 1278(2):183-90. PubMed ID: 8593275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
    Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
    Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin.
    Tsukigawa K; Imoto S; Yamasaki K; Nishi K; Tsutsumi T; Yokoyama S; Ishima Y; Otagiri M
    Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33396604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effect of the protein-doxorubicin conjugates on the multidrug-resistant human myelogenous leukemia cell line, K562, in vitro.
    Hatano T; Ohkawa K; Matsuda M
    Tumour Biol; 1993; 14(5):288-94. PubMed ID: 8235308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
    Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
    Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-life.
    Adams R; Griffin L; Compson JE; Jairaj M; Baker T; Ceska T; West S; Zaccheo O; Davé E; Lawson AD; Humphreys DP; Heywood S
    MAbs; 2016 Oct; 8(7):1336-1346. PubMed ID: 27315033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators.
    Goldwaser I; Qian S; Gershonov E; Fridkin M; Shechter Y
    Mol Pharmacol; 2000 Oct; 58(4):738-46. PubMed ID: 10999943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desferrioxamine enhances the reactivity of vanadium (IV) and vanadium (V) toward ferri- and ferrocytochrome c.
    Stern A; Davison AJ; Wu Q; Moon J
    Free Radic Biol Med; 1992; 12(5):373-80. PubMed ID: 1317325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Dong Y; Uckun FM
    Biochem Biophys Res Commun; 2003 Mar; 302(2):253-64. PubMed ID: 12604339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.